SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Cholongitas, T. Vasiliadis, I. Goulis, I. Fouzas, N. Antoniadis, V. Papanikolaou, E. Akriviadis, Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease, Journal of Viral Hepatitis, 2015, 22, 1
  2. 2
    Amir Kasraianfard, Kymberly D. Watt, Lance Lindberg, Sophoclis Alexopoulos, Nima Rezaei, HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation, International Reviews of Immunology, 2014, 140924103246004

    CrossRef

  3. 3
    Soung Won Jeong, YoungRok Choi, Jin-Wook Kim, Management of viral hepatitis in liver transplant recipients, Clinical and Molecular Hepatology, 2014, 20, 4, 338

    CrossRef

  4. 4
    Evangelos Cholongitas, Ioannis Goulis, Nikolaos Antoniadis, Ioannis Fouzas, George Imvrios, Vasilios Papanikolaou, Evangelos Akriviadis, New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence, Transplant International, 2014, 27, 10
  5. 5
    Georgios Tsoulfas, Polyxeni Agorastou, Commentary on “Prophylaxis against HBV recurrence after liver transplantation for HBV-related endstage liver diseases with severe hypersplenism and splenomegaly: Role of splenectomy”, Journal of Surgical Research, 2013, 183, 2, 548

    CrossRef

  6. 6
    Geoffrey W. McCaughan, Current Management of HBV Pre and Post Liver Transplant, Current Hepatitis Reports, 2013, 12, 2, 119

    CrossRef

  7. 7
    Robert Perrillo, Maria Buti, Francois Durand, Michael Charlton, Adrian Gadano, Guido Cantisani, Che-Chuan Loong, Kimberly Brown, Wenhua Hu, Juan Carlos Lopez-Talavera, Cyril Llamoso, Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B, Liver Transplantation, 2013, 19, 8
  8. 8
    Daniel Shouval, Focus, Journal of Hepatology, 2013, 58, 2, 203

    CrossRef

  9. You have free access to this content9
    Federico G. Villamil, Fernando M. Cairo, Hepatitis B virus: Prevention of recurrent infection, Clinical Liver Disease, 2013, 2, 4
  10. 10
    E. Cholongitas, G.V. Papatheodoridis, High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review, American Journal of Transplantation, 2013, 13, 2
  11. 11
    Jeffrey Campsen, Michael Zimmerman, James Trotter, Johnny Hong, Chris Freise, Robert Brown, Andrew Cameron, Mark Ghobrial, Igal Kam, Ronald Busuttil, Sammy Saab, Curtis Holt, Jean Emond, Jessica Stiles, Thresiamma Lukose, Matthew Chang, Goran Klintmalm, Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues, Liver Transplantation, 2013, 19, 9
  12. You have free access to this content12
    Takuya Genda, Prophylaxis for recurrent hepatitis B virus infection following liver transplantation, Hepatology Research, 2013, 43, 1
  13. You have free access to this content13
    Federico Villamil, Fernando Cairo, Solid organ transplantation and hepatitis B virus, Clinical Liver Disease, 2013, 2, 1
  14. 14
    François Habersetzer, Céline Leboeuf, Michel Doffoël, Mirjam B Zeisel, Thomas F Baumert, Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection, Expert Opinion on Investigational Drugs, 2013, 22, 7, 853

    CrossRef

  15. 15
    Bruno Roche, Didier Samuel, Treatment of Patients with HBV-related Decompensated Cirrhosis and Liver Transplanted Patients, Clinics in Liver Disease, 2013, 17, 3, 451

    CrossRef

  16. 16
    Monica Franciosi, Lucio Caccamo, Paolo De Simone, Antonio Daniele Pinna, Giovanni Giuseppe Di Costanzo, Riccardo Volpes, Vincenzo Scuderi, Paolo Strignano, Patrizia Boccagni, Patrizia Burra, Antonio Nicolucci, Development and validation of a questionnaire evaluating the impact of hepatitis B immune globulin prophylaxis on the quality of life of liver transplant recipients, Liver Transplantation, 2012, 18, 3
  17. 17
    María Buti, Javier García-Samaniego, Martín Prieto, Manuel Rodríguez, José María Sánchez-Tapias, Emilio Suárez, Rafael Esteban, Documento de consenso de la AEEH sobre el tratamiento de la infección por el virus de la hepatitis B (2012), Gastroenterología y Hepatología, 2012, 35, 7, 512

    CrossRef

  18. 18
    E. Cholongitas, T. Vasiliadis, N. Antoniadis, I. Goulis, V. Papanikolaou, E. Akriviadis, Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation, Transplant Infectious Disease, 2012, 14, 5
  19. 19
    Marie A. Laryea, Kymberly D. Watt, Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation, Liver Transplantation, 2012, 18, 5
  20. 20
    Andres F. Carrion, Paul Martin, Christopher O’Brien, Management of Patients with Chronic Hepatitis B Before and After Liver Transplantation: An Update, Current Hepatitis Reports, 2012, 11, 2, 102

    CrossRef

  21. 21
    Tomohiro Tanaka, Ali Benmousa, Max Marquez, George Therapondos, Eberhard L. Renner, Leslie B. Lilly, The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation, Clinical Transplantation, 2012, 26, 5
  22. 22
    Gonzalo Crespo, Zoe Mariño, Miquel Navasa, Xavier Forns, Viral Hepatitis in Liver Transplantation, Gastroenterology, 2012, 142, 6, 1373

    CrossRef

  23. 23
    Wei Wang, Yang Liu, Xiangyang Zu, Rui Jin, Gengfu Xiao, Blocking peptides against HBV: PreS1 protein selected from a phage display library, Biochemical and Biophysical Research Communications, 2011, 412, 4, 633

    CrossRef

  24. 24
    Alfredo Marzano, Management of HBV resistance in the post-transplant setting, Digestive and Liver Disease Supplements, 2011, 5, 1, 19

    CrossRef

  25. 25
    Paolo De Simone, Optimization of hepatitis B virus prophylaxis after liver transplantation, Digestive and Liver Disease Supplements, 2011, 5, 1, 15

    CrossRef